NEOPLASMS OF THE LUNG WITH IMAGING: Edited by Alan Fein and David E. OstTreatment of tobacco dependence current state of the artKathuria, Hasmeenaa; Leone, Frank T.b; Neptune, Enid R.cAuthor Information aThe Pulmonary Center, Boston University Medical Center, Boston University, Boston, Massachusetts bPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania cDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA Correspondence to Enid R. Neptune, MD, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Johns Hopkins School of Medicine, 1830 East Monument Street, Rm 549, Baltimore, MD 21287, USA. Tel: +1 443 287 3348; e-mail: email@example.com Current Opinion in Pulmonary Medicine: July 2018 - Volume 24 - Issue 4 - p 327-334 doi: 10.1097/MCP.0000000000000491 Buy Metrics Abstract Purpose of review The Centers for Medicare and Medicaid Services’ requirement to integrate tobacco treatment with lung cancer screening (LCS) has served as a catalyst for motivating pulmonary medicine clinicians to improve upon their ability to effectively treat tobacco dependence. To do so, clinicians need to be well versed in the behavioral and pharmacologic tools that promote smoking cessation. Recent findings The current review outlines current strategies for treating tobacco dependence, focusing on the important interplay between counseling and pharmacotherapy. Studies that have been found to be particularly effective in patients with smoking-related lung disease and in the LCS setting are reviewed. New therapies that are in the pipeline, as well as novel strategies aimed at improving both adoption and effectiveness of existing therapies, are discussed. Summary Treating tobacco dependence improves mortality and quality of life far more than the limited therapies available to treat smoking-related lung disease. Novel strategies to making tobacco treatment services more widely available, particularly to vulnerable patient populations, are needed to further decrease smoking-related morbidity and mortality. The Affordable Care Act's greater focus on prevention represents a moment of opportunity for healthcare providers and systems to engage in these efforts. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.